European Escherichia coli O104:H4 outbreak  by Chen, Yen-Hsu & Hsueh, Po-Ren
Journal of the Formosan Medical Association (2011) 110, 611e612Available online at www.sciencedirect.com
journal homepage: www.jfma-onl ine.comPERSPECTIVES
European Escherichia coli O104:H4 outbreakYen-Hsu Chen a,b, Po-Ren Hsueh c,*aDivision of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Taiwan
bGraduate Institute of Medicine, Tropical Medicine Research Center, College of Medicine,
Kaohsiung Medical University, Taiwan
cDepartments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital,
National Taiwan University College of Medicine, Taipei, Taiwan
Received 25 June 2010; received in revised form 27 June 2011; accepted 5 July 2011In May 2011, a large outbreak of bloody diarrhea and
enteric infection-related hemolytic uremic syndrome
occurred in numerous European countries as well as in
Canada and the USA (Fig. 1).1 As of 22 June 2011, a total of
3802 infections with Shiga toxin-producing Escherichia coli
serotype O104:H4 had been confirmed. All of the infections
were associated with the consumption of contaminated
bean and seed sprouts.1 Among the 3802 confirmed cases,
2938 (77.3%) involved cases of enterohaemorrhagic E. coli
(EHEC) infection and 864 (22.7%) resulted in hemolytic
uremic syndrome (HUS). This is the first and largest
outbreak of infections due to serotype E. coli O104:H4.
E. coli are Gram-negative and rod-shaped bacteria that
are part of the normal microflora in humans. Although most
strains are harmless, certain serotypes can cause both
intestinal and extraintestinal infections, with manifesta-
tions ranging from mild diarrhea to severe hemorrhagic
colitis and HUS. Based on their virulence factors and
pathogenesis, this group of bacteria has been divided into
several pathotypes, including Shiga toxin-producing E. coli
(STEC).2 Although the most prevalent serotype of E. coli in
previous outbreaks has been O157:H7, the number of
outbreaks due to non-O157 E. coli has increased recently.
Many kinds of foods have been reported to carry STEC,
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doi:10.1016/j.jfma.2011.08.001lettuce.3 At least 150 STEC serotypes have been shown to
be associated with sporadic or cluster illness.3,4 The first
documented outbreak of E. coli O104:H21 infection
occurred in the US state of Montana in 1995,5 and the first
case of HUS caused by E. coli O104:H4 occurred in Korea
in 2006.6
Compared to the O157 serotype, which is colorless and
opaque-appearing on sorbitol-MacConkey agar, most non-
O157 STECs appear as pink colonies and are not easily
detectable on stool culture. 4 However, non-O157 STECs
have accounted for up to 50% of all STEC infections in the
USA.4 In the United States, all stool cultures collected from
patients with acute community-acquired diarrhea are
tested for the presence of E. coli O157 and non-O157 STEC
by detecting the genes or their products related to Shiga
toxins, simultaneously.7
In this outbreak of HUS and EHEC in Europe and in North
America, the majority of patients were 20 years of age or
older (88%) and tended to be female (71%). However, in
previous reports, adults only accounted for 1.5% to 10% of
the infected population, and there was no gender differ-
ence.4 In addition, more than 25% of the patients developed
HUS during this outbreak, which is a much higher rate than
occurred during previous outbreaks.8,9 Epidemiological
studies of the possibility of human-to-human transmission
as well as the risk factors associated with HUS are currently
being conducted by several institutes in Europe.
The E. coli strain O104:H4 has been shown to express
only Shiga toxin 2 (stx2a). In addition, the strain has been
demonstrated to carry the aatA gene (ABC-transporter& Formosan Medical Association. All rights reserved.
Figure 1 The geographical distribution and number of cases of Escherichia coli O104:H4 infection (in parenthesis) in countries in
Europe and in North America.
612 Y.-H. Chen, P.-R. Hsuehprotein gene), the aggR gene (master regulator gene of Vir-
plasmids), the aap gene (secreted protein dispersin), the
aggA gene (AAF/I-fimbral gene), and the aggC gene (AAF/I-
fimbral operon-gene).1 A recent comparative genomic
study showed that several EHECs contained much larger
genomes (5.5-5.9 Mb) and larger numbers of prophages,
integrative elements, and virulence plasmids than non-
EHEC strains. Furthermore, this strain showed multidrug
resistance, including resistance to first and third generation
cephalosporins (through extended-spectrum b-lactamase,
CTX-M-type), tetracycline, nalidixic acid, streptomycin,
and trimethoprim-sulfamethoxazole. These strains devel-
oped through distinct evolutionary tracts and obtained
these mobile genetic elements independently.10 The
evolution of this unusual O104:H4 needs further study.
In Taiwan, physicians need to be aware that patients
who have recently traveled in regions endemic for E. coli
O104:H4 and who present with diarrhea and HUS might be
carriers of non-O157 STECs.
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